CR before results=poor results?, page-13

Agree

Smaller numbers but COVID too

MM has spoken at length about the clearance issue being the target.

Clearing some or most is a massive step forward.

Clearing all is obviously the holy grail.

imo theres a market for both outcomes

Do we need current treatments if BIT is subsequently demonstrated to replicate current treatment and clear resevoirs to some degree (over 6 months)?

What if it gets to the point of being deployed long term, does it clear more?

Per my previous comments, what if its able to be used as a broadspectrum preventative?

Long lasting annual broadspectrum format option, a little like a flu-shot, but for wider target set?

Not there yet, but its a staggering proposition

DYOR